Leonard Bell

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik et al. · Nature Biotechnology · 2007 · 764 citations

Life Sciences, Immunology, Pharmacology +13

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen, Petra Muus, Ulrich Dührsen et al. · Blood · 2007 · 578 citations · Full text

Medicine, Hematology, Pharmacology +11

Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

Anita Hill, Russell P. Rother, Xunde Wang et al. · British Journal of Haematology · 2010 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +13

Site(s) Mediating Sympathetic Activation with Desflurane

Michael Muzi, Thomas J. Ebert, William G. Hope et al. · Anesthesiology · 1996 · 78 citations · Full text

Medicine, Anesthesiology, Pharmacology +14

Preliminary Report of the Effects of Complement Suppression With Pexelizumab on Neurocognitive Decline After Coronary Artery Bypass Graft Surgery

Joseph P. Mathew, Stanton K. Shernan, William D. White et al. · Stroke · 2004 · 62 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17